(Q98713417)
Statements
A first-in-human clinical trial to assess the safety and immunogenicity of a self-amplifying ribonucleic acid (saRNA) vaccine encoding the S glycoprotein of SARS-CoV-2, the causative agent of COVID-19 (English)
0 references
1 April 2020
0 references
31 July 2021
0 references
4 June 2020
0 references
320
0 references